Hosted on MSN1h
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript
The trial will enroll adults aged 65 years and older and is currently ... potential to be antigen-sparing and reduce cost of ...
The News Today8h
‘Pfizer to expand manufacturing and R&D capacities’
Pfizer Limited is expanding its manufacturing capacity and focusing on research and development, said Meenakshi Nevatia, ...
Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript
Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...